News
FMT in a pill: FDA approves second product to prevent C. diff recurrence
- Author:
- Jennie Smith
Clinicians now have two approved options for recurrent infections after antibiotic treatment.
News
Urban green and blue spaces linked to less psychological distress
- Author:
- Jennie Smith
Investigators found that older adults living near parks or lakes saw lower risk of psychological distress. But do these findings have implications...
News
Seven ‘simple’ cardiovascular health measures linked to reduced dementia risk in women
- Author:
- Jennie Smith
Adherence to an American Heart Association guideline, even in part, modulated dementia risk.
News
Headache before the revolution: A clinician looks back
- Author:
- Jennie Smith
To celebrate our 30th year in print, Neurology Reviews invited experts to look back on 30 years of progress in their subspecialty. In this...
News
Cognitive testing for older drivers: Is there a benefit?
- Author:
- Jennie Smith
A policy designed to weed out cognitively impaired drivers over age 75 had the unforeseen effect of exposing them to injuries incurred while...
News
Dietary zinc seen reducing migraine risk
- Author:
- Jennie Smith
New evidence adds the mineral to a growing list of nutritional factors that can influence migraine.
News
NORD Rare Disease Centers of Excellence: A new network seeks to break down barriers in rare disease care
- Author:
- Jennie Smith
“The goal was to find places that could help with unanswered questions, whether diagnostic questions or treatment questions.”
News
The paradox of Pompe disease
- Author:
- Jennie Smith
For nearly 2 decades, patients with even the most severe genetic mutations have been surviving on therapy. But clinicians must now contend with...
News
Smell loss may be a biomarker of Alzheimer’s disease risk
- Author:
- Jennie Smith
Rapidly deteriorating performance on serial smell tests not only predicted Alzheimer’s disease among cognitively normal adults, but corresponded...
News
Will the headache field embrace rofecoxib?
- Author:
- Jennie Smith
The drug formerly known as Vioxx, withdrawn in 2004 over cardiovascular safety concerns, may be given new life as an acute treatment for migraine...
News
Microbleeds, age contribute to ARIA risk with aducanumab
- Author:
- Jennie Smith
New safety results show that brain bleeds at baseline increase risk of brain edema, and that age contributes to risk of bleeds during treatment....
News
Headache seen affecting some pregnancy outcomes
- Author:
- Jennie Smith
A new study links migraine – and also tension-type headache – to small-for-gestational-age babies.
News
Novel gene therapy ‘reprograms’ cells to reverse neurologic deficits in children with rare disease
- Author:
- Jennie Smith
Months after surgery to deliver a gene therapy, children saw complete resolution of oculogyric crises, a hallmark of their disease, and were able...
News
Two case reports identify Guillain-Barré variants after SARS-CoV-2 vaccination
- Author:
- Jennie Smith
Investigators in India and the United Kingdom describe rare presentations of Guillain-Barré syndrome marked by facial paralysis, but evidence of...
News
The aducanumab revolution
- Author:
- Jennie Smith
As the controversial new Alzheimer’s drug makes its way from research settings to the clinic, practitioners brace for a potential sea change in...